Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma (MREO) Exchange Rate Effect (2023 - 2025)

Mereo BioPharma (MREO) has disclosed Exchange Rate Effect for 3 consecutive years, with -$418000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Exchange Rate Effect fell 134.72% to -$418000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $657000.0, a 75.75% decrease, with the full-year FY2024 number at -$233000.0, down 108.27% from a year prior.
  • Exchange Rate Effect was -$418000.0 for Q3 2025 at Mereo BioPharma, down from $1.4 million in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $1.7 million in Q4 2023 to a low of -$1.3 million in Q4 2024.
  • A 3-year average of $409272.7 and a median of $846000.0 in 2023 define the central range for Exchange Rate Effect.
  • Peak YoY movement for Exchange Rate Effect: crashed 174.91% in 2024, then skyrocketed 1433.64% in 2025.
  • Mereo BioPharma's Exchange Rate Effect stood at $1.7 million in 2023, then plummeted by 174.91% to -$1.3 million in 2024, then surged by 66.83% to -$418000.0 in 2025.
  • Per Business Quant, the three most recent readings for MREO's Exchange Rate Effect are -$418000.0 (Q3 2025), $1.4 million (Q2 2025), and $908000.0 (Q1 2025).